AndrewsR SBondC CBurnettJSaundersAWatsonK, (1976) Isolation and identification of paracetamol metabolites. The Journal of International Medical Research4, Supplement (4), 34.
2.
AxelrodJ, (1956) The enzymic cleavage of aromatic ethers. Biochemical Journal63, (4) 634.
3.
AzenE ABryanG TShahidiN TRossiE CClatanoffD V, (1970) Obscure hemolytic anemia due to analgesic abuse. American Journal of Medicine48, (6) 724.
4.
BoréusL-OSandbergF, (1953) A comparison of some pharmacological effects of acetophenetidin and N-acetyl-p-aminophenol. Acta physiologica Scandinavica28, 261.
5.
BrodieB BAxelrodJ, (1948a) The physiological disposition of acetophenetidin (p-ethoxyacetanilide) in man. Federation Proceedings7, 207.
6.
BrodieB BAxelrodJ, (1948b) The fate of acetanilide in man. Journal of Pharmacology and Experimental Therapeutics94, 29.
7.
BrodieB BAxelrodJ, (1949) Metabolic fate of acetophenetidin in man. Journal of Pharmacology and Experimental Therapeutics97, 58.
8.
BüchHHäuserHPflegerKRüdigerW, (1966) Über die Ausscheidung eines noch nicht beschriebenen phenacetinmetaboliten beim Menschen und bei der Ratte. Naunyn-Schmiedeberg's Archiv für experimentelle Pathologie und Pharmakologie235, 25.
9.
BüchHPflegerKRummelWUllrichVHeyDStaudingerH J, (1967) Untersuchungen über den oxydativen Stoffwechsel des Phenacetin's bei der Ratte. Biochemical Pharmacology16, (12) 2247.
10.
BurnsJ JConneyA H, (1965) Biochemical studies with phenacetin and related compounds. Experimental studies and clinical experience.—The assessment of risk. Proceedings of the European Society for the Study of Drug ToxicologyVI, 76.
11.
ClarkRBorirakchanyavatVDavidsonA RThompsonR P HWiddopBGouldingRWilliamsR, (1973) Hepatic damage and death from overdose of paracetamol. Lancet1, (7794) 66.
12.
DaussetJContuL, (1964) A case of haemolytic anaemia due to phenacetin allergy. Vox sanguinis9, 599.
13.
DernR JBeutlerEAlvingA S, (1955) The haemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. Journal of Laboratory and Clinical Medicine45, 30.
14.
DollGHackenthalE, (1963) Untersuchungen über Phenacetin und einige chemisch verwandte substanzen. Arzneimittel-Forschung13, 68.
15.
DubachU CRosnerBMüllerALeyvP SBaumelerH RPeierA, (1975) Relation between regular intake of phenacetin-containing analgesics and laboratory evidence for uro-renal disorders in a working female population of Switzerland. Lancet1, (7906) 539.
16.
EadeN RLasagnaL, (1967) A comparison of acetophenetidin and acetaminophen. II. Subjective effects in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics155, 301.
17.
Editorial (1973) Analgesics and the kidney. British Medical Journal3, 123.
18.
EdlefsenG, (1900) Zum Nachweise des Phenetidins im Harn. Zentralblatt für innere Medizin21, 2.
19.
EdwardsO MEdwardsPHuskissonE CTaylorR T, (1971) Paracetamol and renal damage. British Medical Journal2, 87.
20.
EisnerE VShahidiN T, (1972) Immune thrombocytopenia due to a drug metabolite. New England Journal of Medicine287, 376.
21.
FriisTFoghJNissenN I, (1960) The mechanism of reduction of erythrocyte lifetime in phenacetin habitués with renal impairment. Acta Medica Scandinavica, 168, 127.
22.
GaultM HShahidiN TBarberV E, (1974) Methaemoglobin formation in analgesic nephropathy. Clinical Pharmacology and Therapeutics15, 521.
23.
GreenbergL ALesterD, (1947) The metabolic fate of acetanilid and other aniline derivatives. III. The role of p-aminophenol in the production of methemoglobinemia after acetanilid. Journal of Experimental Therapeutics90, 150.
24.
HeymannEKrischikKBüchHBuzelloW, (1969) Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor bis(p-nitrophenyl)phosphate. Biochemical Pharmacology18, (4) 801.
25.
HinsbergOTreupelG, (1894) Über die physiologische Wirkung des p-Amidophenols und einiger Derivate desselben. Archiv für experimentelle Pathologie und Pharmakologie33, 216.
26.
JaffeE R, (1971) Methaememoglobinaemia and Sulphaemoglobinaemia. Cecil Loeb Textbook of Medicine XIII Edition, 1699.
27.
KerrD, (1970) Phenacetin nephropathy. British Medical Journal4, 363.
28.
KieseMMenzelH, (1962) Hamiglobinbildung im Blute des Menschen nach Einnahme von Phenacetin und von N-Acetyl-p-aminophenol. Naunyn-Schmiedeberg's Archiv für experimentelle Pathologie und Pharmakologie242, 551.
29.
KoblerG, (1887) Das Acetphenetidin als Antipyreticum. Wiener medizinische Wochenschrift37, 865.
30.
KriklerD M, (1967) Paracetamol and the kidney. British Medical Journal2, 615.
31.
KrischK, (1966) Reaction of a microsomal esterase from hog-liver with diethyl p-nitrophenyl phosphate. Biochimica et biophysica acta122, 265.
32.
LewinL, (1893) Über die Nebenwirkung der Arzneimittel. A Hirschwald, Berlin, 10, 549.
33.
LorenzenISchwartzM, (1960) Phenacetin-induced haemolysis in patients with chronic nephritis and phenacetin abuse. Acta Medica Scandinavica168, 461.
34.
MacGibbonB HLoughridgeL WHourihaneD O'BBoydD W, (1960) Autoimmune haemolytic anaemia with acute renal failure due to phenacetin and p-aminosalicylic acid. Lancet1, 7.
35.
MasterD R, (1973) Analgesic nephropathy associated with paracetamol. Proceedings of the Royal Society of Medicine66, 904.
36.
Mering vonJ, (1893) Beiträge zur Kenntniss der Antipyretica. Therapeutische Monatshefte7, 577.
37.
MillarJPéloquinRde LeeuwN K M, (1972) Phenacetin-induced hemolytic anemia. Canadian Medical Association Journal106, 770.
38.
MüllerF R, (1888) Über Acetphenetidin. Berliner Klinische Wochenschrift30, 613.
39.
MuirheadE EHaldenE RGrovesM, (1958) Drug-dependent combs (antiglobulin) test and anemia observations on quinine and acetophenetidin (phenacetin). Archives of Internal Medicine101, 87.
40.
NeryR, (1971) The possible role of N-hydroxylation in the biological effects of phenacetin. Xenobiotica1, 339.
41.
NissenN IFriisT, (1962) Further study of the mechanism of reduction of erythrocyte survival time in phenacetin habitués and its relation to “phenacetin kidney disorders”. Acta Medica Scandinavica171, 125.
42.
PrankerdT A J, (1964) Enzymes and drug sensitivity. Glucose 6-phosphate dehydrogenase deficiency. Proceedings of the Royal Society of Medicine57, 506.
43.
PrescottL FSteelR FFerrierW R, (1970) The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system. Clinical Pharmacology and Therapeutics11, 496.
44.
PrescottL FWrightN, (1973) The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. British Journal of Pharmacology and Chemotherapy49, (4) 602.
45.
ProudfoodA TWrightN, (1970) Acute paracetamol poisoning. British Medical Journal3, 557.
46.
RaaflaubJDubachU C, (1969) Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klinische Wochenschrift47, 1286.
47.
ShahidiN T, (1968) Hematotoxic effects of acetophenetidin. Hospital Practice3, 73.
48.
ShahidiN THemaidanA J, (1969) Acetophenetidin-induced methemoglobinemia and its relation to the excretion of diazotizable amines. Journal of Laboratory and Clinical Medicine74, (4) 581.
49.
SkokanJ DHewlettJ SHoffmanG C, (1973) Thrombocytopenic purpura associated with ingestion of acetaminophen (Tylenol). Cleveland Clinic Quarterly40, (2) 89.
50.
SmithJ NWilliamsR T, (1949) Studies in detoxication. 22. The metabolism of phenacetin (p-ethoxyacetanilide) in the rabbit and a further observation on acetanilide metabolism. Biochemical Journal44, 239.
Sterling Winthrop Research Files ThomasB HColdwellB BZeitzWSolomonraiG, (1972) Effect of aspirin, caffeine and codeine on the metabolism of phenacetin and acetominophen. Clinical Pharmacology and Therapeutics, 13, 906.
53.
ThomasJMcLeanSStarmerG ACarrollP P, (1966) Paracetamol and methaemoglobinaemia. Lancet2, (7477) 1360.
54.
TreupelG, (1895) Beiträge zur Kenntniss der Antipyretica und Antalgica. Deutsche medizinische Wochenschrift21, 222.
55.
UehlekeH, (1973) Biochemical pharmacology and toxicology of phenacetin. International Symposium on Problems of Phenacetin Abuse, 31.
